about
Identifying HIV-1 dual infectionsEvidence of Recombination in Intrapatient Populations of Hepatitis C VirusClinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis CRapid intracellular competition between hepatitis C viral genomes as a result of mitosis.Evaluation of cross-reactive antibody response to HVR1 in chronic hepatitis C.The hepatitis C virus core protein can modulate RNA-dependent RNA synthesis by the 2a polymerase.Dynamic coinfection with multiple viral subtypes in acute hepatitis C.Molecular and contextual markers of hepatitis C virus and drug abuse.Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1bHepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionEvidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.Innate immune sensing of HIV-1 by dendritic cells.Human papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen's disease.Independence of Anaplasma marginale strains with high and low transmission efficiencies in the tick vector following simultaneous acquisition by feeding on a superinfected mammalian reservoir host.Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic ReviewMixed HCV infection and reinfection in people who inject drugs--impact on therapy.Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy.Next-Generation Sequencing of 5' Untranslated Region of Hepatitis C Virus in Search of Minor Viral Variant in a Patient Who Revealed New Genotype While on Antiviral Treatment.Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy.Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan.Understanding and addressing hepatitis C reinfection in the oral direct acting antiviral era.
P2860
Q22241756-3CB27177-75CF-4DF0-BB8F-E18543F49BB5Q27486806-7CDDE947-76D3-4537-8B42-276ED208CBDFQ28080225-26A182BC-B89E-4710-8BA6-C89F4C7283C8Q30531290-5350276E-F95B-44A2-A757-0A6696DF4978Q34134998-4EFF3D5F-BFB3-4390-8E44-F2581DB15094Q34518202-9C2F0928-B5F9-4AD2-8B87-6853C0AF4183Q35022787-EBEF414C-4FC9-4FFD-A8F6-70556A352E19Q35660841-9102D8AA-95DE-406F-8BE2-E9E57C45CAB2Q35826504-EC0A68EF-6D3B-447F-8496-6D6293763BC3Q35846408-A51CC9CD-352C-4371-AEA7-159B6A1E86FDQ36079814-FC822A22-166A-4CBF-8E81-F2B44C9C8F57Q36748027-547C9517-7810-4E27-9CA6-D4E4ECED1C00Q37035380-370C31A8-9E02-43DA-AF90-FF4273520E78Q37145049-D259FC89-28BC-4BDB-86F7-1050534D15D0Q37587065-2E73F7FA-565B-4D34-9B1E-D1FF6E3036A1Q38381584-41824967-75F7-406A-A44B-ECCDB44ADE5DQ38573508-F42E4F10-D52C-4403-B3AF-C3C241107752Q39032538-05AA65D2-637E-484F-B885-787C49E4CAFAQ40127553-019192CC-CD8B-4510-AF90-496051C2BB8BQ40611739-EF941423-762C-4A66-9190-664AA8BCFF56Q42982341-9CB3154A-D941-4F03-8897-1290FF9FFCE0Q44035597-CBAF7F88-3B53-442C-9E61-1ADF388AD76BQ47274505-09EEE69C-02A9-4205-AA88-DEADA5E06A79
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hepatitis C virus coinfection and superinfection.
@ast
Hepatitis C virus coinfection and superinfection.
@en
type
label
Hepatitis C virus coinfection and superinfection.
@ast
Hepatitis C virus coinfection and superinfection.
@en
prefLabel
Hepatitis C virus coinfection and superinfection.
@ast
Hepatitis C virus coinfection and superinfection.
@en
P356
P1476
Hepatitis C virus coinfection and superinfection.
@en
P2093
Jason T Blackard
Kenneth E Sherman
P304
P356
10.1086/510858
P407
P577
2007-01-11T00:00:00Z